Potential for Bispecific T-Cell Engagers: Role of Blinatumomab in Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s83848
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Blinatumomab in Acute Lymphoblastic Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Targeting IRAK1 in T-Cell Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2015English

Leukemia-Initiating Cell Activity Requires Calcineurin in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

Inhibition of MerTK Increases Chemosensitivity and Decreases Oncogenic Potential in T-Cell Acute Lymphoblastic Leukemia

Blood Cancer Journal
OncologyHematology
2013English

CAR T Cells for Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2019English

Correlates of Resistance and Relapse During Blinatumomab Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2017English

T-Cell Acute Lymphoblastic Lymphoma (T-Lbl) and Stem Cell Transplantation (SCT): A Comparison of Outcomes With T-Cell Acute Lymphoblastic Leukemia (T-All)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy